Abstract
Due to the complexity of its cellular composition and its topographical anatomy, no other organ can be affected by such a variety of different neoplasms as the central nervous system. Therefore, one of the most important developments in neuro-oncology was the formulation of a comprehensive and internationally accepted classification system, which provides a basis for the communication between neuropathologists and clinicians, working in clinical and basic neuro-oncology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bigner SH, Mark J, Bigner DD (1990) Cytogenetics of human brain tumors. Cancer Genet Cytogenet 47;141–154.
Bravo R, Frank R, Blundell PA, MacDonald-Bravo H (1987) Cyclin/PCNA is the auxiliary protein of DNA polymerase alpha. Nature 326:515–517.
Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlated with advanced disease stage. Science 224:1121–1124.
Burger PC, Shibata T, Kleihues P (1986) The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical pathology. Am J Surg Pathol 10:611–617.
Celis JE, Celis A (1985) Cell cycle dependent variations in the distribution of the nuclear protein cyclin/proliferating cell nuclear antigen in cultured cells: subdivision of S-phase. Proc Natl Acad Sci USA 82:3262–3266.
Cho KG, Nagashima T, Bamwell S, Hoshino T (1988b) Flow cytometric determination of modal DNA population in relation to proliferative potential of human intracranial neoplasms. J Neurosurg 69:588–592.
Danova M, Riccardi A, Gaetani P, Wilson GD, Mazzini G, Brugnatelli S, Buttini R, Butti G, Ucci G, Paoletti P, Ascari E (1988) Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry. Eur J Cancer Clin Oncol 24:873–880.
Deckert M, Reifenberger G, Wechsler W (1989) Determination of the proliferative activity of human brain tumors using the monoclonal antibody Ki-67. J Cancer Res Clin Oncol 115:179–188.
Garson JA, Pemberton LF, Sheppard PW, Varndell IM, Coakham HB, Kemshead JT (1989) N-myc gene expression and oncoprotein characterization in medulloblastoma. Br J Cancer 59:889–894.
Gerosa MA, Talarico D, Fognani C, Raimondi E, Colombatti M, Tridente G, De Carli L, Della Valle G (1989) Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas. J Natl Cancer Inst 81:63–67.
Gratzner HG (1982) Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218:474–475.
Grunberger G, Lowe WL, McElduff A, Glick RP (1986) Insulin receptor of human cerebral gliomas-structure and function. J Clin Invest 77:997–1005.
Hanley MR (1988) Proto-oncogenes in the nervous system. Neuron 1:175–182.
Hinton DR (1990) Morphologic and biochemical analysis of the antigen defined by antibody Ki-67. J Neuropathol Exp Neurol 49:321 (abstract).
Hoshino T, Nagashima T, Cho KG, Murovic JA, Hodes JE, Wilson CB, Edwards MSB, Pitts LH (1986a) S-phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine. Int J Cancer 38:369–374.
Hoshino T, Nagashima T, Murovic J, Levin EM, Levin VA, Rupp SM (1985) Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry 6:627–632.
Hoshino T, Nagashima T, Murovic J, Wilson CB, Edwards MSB, Gutin PH, Davis RL, DeArmond SJ (1986b) In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg 64:453–459.
Hoshino T, Nagashima T, Murovic JA, Wilson CB, Davis RL (1986c) Proliferative potential of human meningiomas of brain: a cell kinetic study with bromodeoxyuridine. Cancer 58:1466–1472.
Hoshino T, Nomura K, Wilson CB, Knebel KD, Gray JW (1978) The distribution of nuclear DNA from human brain-tumor cells. J Neurosurg 49:13–21.
James CD, Carlbon E, Nordenskjold E, Collins VP, Cavenee WK (1989) Mitotic recombinationa of chromosome 17 in astrocytomas. Proc Natl Acad Sci USA 86:2858–2862.
Jaskulski D, DeRiel JK, Mercer WE, Calabretta B, Baserga R (1988) Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA/cyclin. Science 240:1544–1546.
Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O’Brien SJ, Wong AJ, Vogelstein B (1987) Identification of an amplified, highly expressed gene in a human glioma. Science 236:70–73.
Kleihues P, Kiessling M, Janzer RC (1987a) Morphological markers in neuro-oncology. Curr Top Pathol 77:307–338.
Kleihues P, Sarioglu A, Shibata T, Yasargil GM (1989) Ki-67 expression in the glioblastoma multiforme: correlation between growth fraction and patient survival. Clin Neuropathol (in press)(abstract).
Klein G (1987) The approaching era of the tumor suppressor genes. Science 238:1539–1545.
Landolt AM, Shibata T, Kleihues P (1987) Growth rate of human pituitary adenomas. J Neurosurg 67:803–806.
Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313:144–147.
Louis DN, Edgerton S, Thor AD, Hedley-Whyte ET (1990) Proliferating cell nuclear antigen (PCNA) in human nervous system tumors. J Neuropathol Exp Neurol 49:272 (abstract).
Marks F (1987) What’s new in oncogenes and growth factors?. Path Res Pract 182:831–848.
Mushika M, Miwa T, Suzuoki Y, Hayashi K, Masaki S, Kaneda T (1988) Detection of proliferative cells in dysplasia, carcinoma in situ, and invasive carcinoma of the uterine cervix by monoclonal antibody against DNA polymerase alpha. Cancer 61:1182–1186.
Nagashima T, Hoshino T, Cho K, Senegor M, Waldman F, Nomura K (1988a) Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors. J Neurosurg 68:388–392.
Nagashima T, Hoshino T, Cho KG, Edwards MSB, Hudgins RJ, Davis RL (1988b) The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling. Cancer 61:2433–2438.
Nagashima T, Murovic JA, Hoshino T, Wilson CB, DeArmond SJ (1986b) The proliferative potential of human pituitary tumors in situ. J Neurosurg 64:588–593.
Nigro JM, Baker SJ, Jessup JM, Hostetter R, Bigner SH, Devilee P, Glover T, Westin A, Harris C, Vogelstein B (1989) p53 gene mutations occur in diverse tumot types. Nature 342:705–708.
Nishizaki T, Orita T, Furutani Y, Ikeyama Y, Aoki H, Sasaki K (1989) Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors. J Neurosurg 70:379–384.
Prior R, Reifenberger G, Wechsler W (1989) Nerve growth factor receptor in tumors of the human nervous system. Immunohistochemical analysis of receptor expression and growth fraction. Pathol Res Pract 185:332–338.
Reifenberger G, Szymas J, Wechsler W (1987) Differential expression of glial-and neuronal-associated antigens in human tumors of the central and peripheral nervous system. Acta Neuropathol 74: 105–123.
Sasaki K, Matsumura K, Tsuji T, Shinozaki F, Takahashi M (1988) Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors. Cancer 62:989–993.
Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111–1116.
Stavrou D, Keiditsch E, Schmidberger F, Bise K, Funke I, Eisenmenger W, Kuurle R, Martin B, Stocker U (1987) Monoclonal antibodies against human astrocytomas and their reactivity pattern. J Neurol Sci 80:205–220.
Trent J, Meltzer P, Rosenblum M, Harsh G, Kinzler K, Marshal R, Feinberg A, Vogelstein B (1986) Evidence for reaarangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci USA 83:470–473.
Tsuda T, Obara M, Hirano H, Gotoh S, Kubomura S, Higashi K, Kuroiwa A, Nakagawara A, Nagahara N, Shimizu K (1987) Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas. Cancer 60:820–826.
Zovickian J, Johnson VG, Youle RJ (1987) Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin. J Neurosurg 66:850–861.
Zülch KJ (1979) Histological typing of tumours of the central nervous system. WHO Geneva
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Wechsler, W., Reifenberger, G. (1991). Immunohistochemistry in Brain Tumor Classification. In: Paoletti, P., Takakura, K., Walker, M.D., Butti, G., Pezzotta, S. (eds) Neuro-Oncology. Developments in Oncology, vol 66. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3152-0_2
Download citation
DOI: https://doi.org/10.1007/978-94-011-3152-0_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5390-7
Online ISBN: 978-94-011-3152-0
eBook Packages: Springer Book Archive